61314-504-63 : NDC 2026 Code

61314-504-63 : Aflibercept ( Enzeevu )

Additionally :

You can get information about “61314-504-63” NDC code in 61314-504-63 in HTML format

HTML | 61314-504-63 in TXT (Plain Text) format

TXT | 61314-504-63 in PDF (Portable Document Format)

PDF | 61314-504-63 in XML format

XML formats.

NDC Code : 61314-504-63 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "61314-504-63",
    "PackageDescription": "1 SYRINGE, GLASS in 1 CARTON (61314-504-63)  / .05 mL in 1 SYRINGE, GLASS",
    "NDC11Code": "61314-0504-63",
    "ProductNDC": "61314-504",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Enzeevu",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Aflibercept",
    "DosageFormName": "INJECTION, SOLUTION",
    "RouteName": "INTRAVITREAL",
    "StartMarketingDate": "20261026",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761382",
    "LabelerName": "Sandoz Inc",
    "SubstanceName": "AFLIBERCEPT",
    "StrengthNumber": "2",
    "StrengthUnit": "mg/.05mL",
    "Pharm_Classes": "Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-10-27",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20261026",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}